Drug Information Association To Host 21st Annual Conference On Marketing Pharmaceuticals In A Time Of Change

Main Category: Pharmacy / Pharmacist
Article Date: 15 Jan 2009 - 1:00 PDT

email to a friend   printer friendly   opinions  

Marketing, legal, regulatory, public relations/affairs, advertising, compliance and management, and communications professionals are invited to participate in the Drug Information Association's (DIA's) 21st Annual DIA Conference on Marketing Pharmaceuticals in a Time of Change (February 23-25, 2009; New York, NY).

"This conference will provide a basic understanding of how the regulatory and legal environment has evolved and affects the marketing and promotion of pharmaceuticals," explains Minnie Baylor--Henry, JJD, Program Committee Member and Treasurer of the DIA Board of Directors. "It also provides practical, day-to-day guidance on what can be learned from the latest FDA enforcement actions, and how companies can do their jobs better."

This year's program will focus on enforcement by the three centers within FDA that regulate drugs, biological products and veterinary drugs, direct-to-consumer advertising, state regulations, and the oversight of off-label issues by the Office of Inspector General and Department of Justice. The conference will also explore the latest innovations in the use of the internet for product communication. Highlights will include:

- FDA Update: Recent Enforcement Actions
- DTC Update from DDMAC
- Enforcement Updates: New Trends in State and Federal Enforcement
- Ethics in Marketing Pharmaceuticals: Panel Discussion
- Online and Mobile Technologies
- Promoting to Subsets of the General Population
- Implementation of the Revised PhRMA Code
- FDA Policy on the Distribution of Peer-reviewed Reprints from Medical Journals
- Latest Status of Industry's Role in CME
- Global Initiatives
- Question and Answer Session with FDA

About the Drug Information Association (DIA)

DIA serves more than 30,000 professionals in the biotechnology, pharmaceutical and regulatory industries worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team.

Drug Information Association

• Additional
• References
• Citations